Revised SPCs: Neoclarityn (desloratadine) 5 mg film-coated tablets and oral solution

Undesirable effects section updated to reflect increased incidence of new-onset seizure in patients age 0 to 19 years when receiving desloratadine compared with periods not receiving desloratadine based on the results of the final report from a study.


electronic Medicines compendium